VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma.
Biomarker-Integrated Neoadjuvant Dasatinib Trial in Resectable Malignant Pleural Mesothelioma. J Thorac Oncol. 2018 02; 13(2):246-257.
View in:
PubMed
subject areas
Aged
Antineoplastic Agents
Dasatinib
Female
Humans
Lung Neoplasms
Male
Mesothelioma
Middle Aged
Pleural Neoplasms
authors with profiles
DAVID C RICE
ANNE TSAO
IGNACIO IVAN WISTUBA
JUNYA FUJIMOTO
REZA JOHN MEHRAN
JOHN VICTOR HEYMACH
BRETT CARTER